Deaton Rebecca A, Su Chang, Valencia Thomas G, Grant Stephen R
Cardiovascular Research Institute, Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth, Texas 76107-2699, USA.
J Biol Chem. 2005 Sep 2;280(35):31172-81. doi: 10.1074/jbc.M504774200. Epub 2005 Jun 26.
Differentiated vascular smooth muscle cells (SMCs) exhibit a work phenotype characterized by expression of several well documented contractile apparatus-associated proteins. However, SMCs retain the ability to de-differentiate into a proliferative phenotype, which is involved in the progression of vascular diseases such as atherosclerosis and restenosis. Understanding the mechanisms involved in maintaining SMC differentiation is critical for preventing proliferation associated with vascular disease. In this study, the molecular mechanisms through which transforming growth factor-beta1 (TGF-beta1) induces differentiation of SMCs were examined. TGF-beta1 stimulated actin re-organization, inhibited cell proliferation, and up-regulated SMC marker gene expression in PAC-1 SMCs. These effects were blocked by pretreatment of cells with either HA1077 or Y-27632, which inhibit the kinases downstream of RhoA. Moreover, TGF-beta1 activated RhoA and its downstream target PKN. Overexpression of active PKN alone was sufficient to increase the transcriptional activity of the promoters that control expression of smooth muscle (SM) alpha-actin, SM-myosin heavy chain, and SM22alpha. In addition, PKN increased the activities of serum-response factor (SRF), GATA, and MEF2-dependent enhancer-reporters. RNA interference-mediated inhibition of PKN abolished TGF-beta1-induced activation of SMC marker gene promoters. Finally, examination of MAPK signaling demonstrated that TGF-beta1 increased the activity of p38 MAPK, which was required for activation of the SMC marker gene promoters. Co-expression of dominant negative p38 MAPK was sufficient to block PKN-mediated activation of the SMC marker gene promoters as well as the serum-response factor, GATA, and MEF2 enhancers. Taken together, these results identify components of an important intracellular signaling pathway through which TGF-beta1 activates PKN to promote differentiation of SMCs.
分化的血管平滑肌细胞(SMC)表现出一种工作表型,其特征是表达几种有充分文献记载的与收缩装置相关的蛋白质。然而,SMC保留了去分化为增殖表型的能力,这与动脉粥样硬化和再狭窄等血管疾病的进展有关。了解维持SMC分化的机制对于预防与血管疾病相关的增殖至关重要。在本研究中,研究了转化生长因子-β1(TGF-β1)诱导SMC分化的分子机制。TGF-β1刺激肌动蛋白重新组织,抑制细胞增殖,并上调PAC-1 SMC中SMC标记基因的表达。用HA1077或Y-27632预处理细胞可阻断这些作用,这两种药物可抑制RhoA下游的激酶。此外,TGF-β1激活RhoA及其下游靶点PKN。单独过表达活性PKN足以增加控制平滑肌(SM)α-肌动蛋白、SM-肌球蛋白重链和SM22α表达的启动子的转录活性。此外,PKN增加了血清反应因子(SRF)、GATA和MEF2依赖性增强子报告基因的活性。RNA干扰介导的PKN抑制消除了TGF-β1诱导的SMC标记基因启动子的激活。最后,对MAPK信号的检测表明,TGF-β1增加了p38 MAPK的活性,这是激活SMC标记基因启动子所必需的。共表达显性负性p38 MAPK足以阻断PKN介导的SMC标记基因启动子以及血清反应因子、GATA和MEF2增强子的激活。综上所述,这些结果确定了一条重要的细胞内信号通路的组成部分,通过该通路TGF-β1激活PKN以促进SMC的分化。